Volume 23, Issue 1 pp. 25-29

Serum uric acid levels in cardiovascular diseases

M. Torun

M. Torun

Department of Biochemistry, Faculty of Pharmacy, Gazi University, 06330, Hipodrom, Ankara, Turkey

Search for more papers by this author
S. Yardım

S. Yardım

Department of Biochemistry, Faculty of Pharmacy, Gazi University, 06330, Hipodrom, Ankara, Turkey

Search for more papers by this author
B. Simsek

B. Simsek

Department of Biochemistry, Faculty of Pharmacy, Gazi University, 06330, Hipodrom, Ankara, Turkey

Search for more papers by this author
S. Burgaz

S. Burgaz

Department of Toxicology, Faculty of Pharmacy, Gazi University, 06330, Hipodrom, Ankara, Turkey

Search for more papers by this author
First published: 09 October 2008
Citations: 15
M.Torun

Abstract

Objective: Comparison of the serum uric acid levels of healthy people ( n=71) and patients with cardiovascular diseases (CVD) (n=62). Subjects and methods: The patients included had either experienced acute myocardial infarction (AMI) ( n=31), atherosclerosis (AT) (n=23) or ischaemia ( n=8). The mean values (x±SD) of serum uric acid levels of the control group, the patients with CVD as a whole, and patients with AMI, AT and ischaemia were 4·15±0·45 mg%, 5·6±2·06 mg%, 5·96±2·60 mg%, 5·38±1·22 mg% and 4·94±1·40 mg%, respectively. A statistically higher level of serum uric acid was found in the controls compared to the CVD patients ( P < 0·05). Conclusion: The higher serum uric acid levels found in CVD patients suggests that any protective antioxidant effect which uric acid has is overwhelmed by other negative effects on pathogenesis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.